184 related articles for article (PubMed ID: 21835049)
1. Cathepsin B trafficking in thyroid carcinoma cells.
Tedelind S; Jordans S; Resemann H; Blum G; Bogyo M; Führer D; Brix K
Thyroid Res; 2011 Aug; 4 Suppl 1(Suppl 1):S2. PubMed ID: 21835049
[TBL] [Abstract][Full Text] [Related]
2. Nuclear cysteine cathepsin variants in thyroid carcinoma cells.
Tedelind S; Poliakova K; Valeta A; Hunegnaw R; Yemanaberhan EL; Heldin NE; Kurebayashi J; Weber E; Kopitar-Jerala N; Turk B; Bogyo M; Brix K
Biol Chem; 2010 Aug; 391(8):923-35. PubMed ID: 20536394
[TBL] [Abstract][Full Text] [Related]
3. Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment.
Linke M; Herzog V; Brix K
J Cell Sci; 2002 Dec; 115(Pt 24):4877-89. PubMed ID: 12432075
[TBL] [Abstract][Full Text] [Related]
4. Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe.
Al-Hashimi A; Venugopalan V; Rehders M; Sereesongsaeng N; Hein Z; Springer S; Weber E; Führer D; Bogyo MS; Scott CJ; Burden RE; Brix K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266306
[TBL] [Abstract][Full Text] [Related]
5. Observing proteases in living cells.
Moin K; Demchik L; Mai J; Duessing J; Peters C; Sloane BF
Adv Exp Med Biol; 2000; 477():391-401. PubMed ID: 10849765
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.
Naganawa Y; Itoh K; Shimmoto M; Kamei S; Takiguchi K; Doi H; Sakuraba H
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):467-74. PubMed ID: 10333491
[TBL] [Abstract][Full Text] [Related]
7. Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells.
Al-Hashimi A; Venugopalan V; Sereesongsaeng N; Tedelind S; Pinzaru AM; Hein Z; Springer S; Weber E; Führer D; Scott CJ; Burden RE; Brix K
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118846. PubMed ID: 32910988
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rat thyrocytes in vitro with cathepsin B and L inhibitors results in disruption of primary cilia leading to redistribution of the trace amine associated receptor 1 to the endoplasmic reticulum.
Szumska J; Batool Z; Al-Hashimi A; Venugopalan V; Skripnik V; Schaschke N; Bogyo M; Brix K
Biochimie; 2019 Nov; 166():270-285. PubMed ID: 31302164
[TBL] [Abstract][Full Text] [Related]
9. Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.
Jordans S; Jenko-Kokalj S; Kühl NM; Tedelind S; Sendt W; Brömme D; Turk D; Brix K
BMC Biochem; 2009 Sep; 10():23. PubMed ID: 19772638
[TBL] [Abstract][Full Text] [Related]
10. Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cells.
Tamhane T; Lllukkumbura R; Lu S; Maelandsmo GM; Haugen MH; Brix K
Biochimie; 2016 Mar; 122():208-18. PubMed ID: 26343556
[TBL] [Abstract][Full Text] [Related]
11. Investigations on Primary Cilia of Nthy-ori 3-1 Cells upon Cysteine Cathepsin Inhibition or Thyrotropin Stimulation.
Doğru AG; Rehders M; Brix K
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298246
[TBL] [Abstract][Full Text] [Related]
12. Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells.
Qatato M; Venugopalan V; Al-Hashimi A; Rehders M; Valentine AD; Hein Z; Dallto U; Springer S; Brix K
Cells; 2021 Jun; 10(6):. PubMed ID: 34208608
[TBL] [Abstract][Full Text] [Related]
13. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
14. Functional defects in lysosomal enzymes in autosomal dominant polycystic kidney disease (ADPKD): abnormalities in synthesis, molecular processing, polarity, and secretion.
Hartz PA; Wilson PD
Biochem Mol Med; 1997 Feb; 60(1):8-26. PubMed ID: 9066978
[TBL] [Abstract][Full Text] [Related]
15. Construction of a plasmid coding for green fluorescent protein tagged cathepsin L and data on expression in colorectal carcinoma cells.
Tamhane T; Wolters BK; Illukkumbura R; Maelandsmo GM; Haugen MH; Brix K
Data Brief; 2015 Dec; 5():468-75. PubMed ID: 26594658
[TBL] [Abstract][Full Text] [Related]
16. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells.
Brix K; Lemansky P; Herzog V
Endocrinology; 1996 May; 137(5):1963-74. PubMed ID: 8612537
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteinases mediate extracellular prohormone processing in the thyroid.
Brix K; Linke M; Tepel C; Herzog V
Biol Chem; 2001 May; 382(5):717-25. PubMed ID: 11517924
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
[TBL] [Abstract][Full Text] [Related]
20. [Changes in active cysteine cathepsins in lysosomes from tissues thyroid papillary carcinomas with various biological characteristics].
Kalinichenko OV; Myshunina TM; Tron'ko MD
Fiziol Zh (1994); 2013; 59(5):11-9. PubMed ID: 24400560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
